Phase IC Study of Safety and PK of SQ109 300mg Daily

This study has been completed.
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID) Identifier:
First received: November 18, 2010
Last updated: May 10, 2013
Last verified: May 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2011
  Primary Completion Date: February 2011 (Final data collection date for primary outcome measure)